Patriot Financial Group Insurance Agency’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-355
Closed -$12K 1007
2022
Q2
$12K Hold
355
﹤0.01% 1178
2022
Q1
$13K Sell
355
-65
-15% -$2.23K ﹤0.01% 1258
2021
Q4
$17K Hold
420
﹤0.01% 1285
2021
Q3
$18K Buy
420
+65
+18% +$2.92K ﹤0.01% 1257
2021
Q2
$14K Hold
355
﹤0.01% 1321
2021
Q1
$12K Hold
355
﹤0.01% 1290
2020
Q4
$14K Hold
355
﹤0.01% 1102
2020
Q3
$13K Sell
355
-500
-58% -$18.1K ﹤0.01% 944
2020
Q2
$29K Buy
855
+735
+613% +$20K 0.01% 649
2020
Q1
$3K Buy
+120
New +$2.67K ﹤0.01% 1210

Other funds holding GMAB

Patriot Financial Group Insurance Agency's GMAB Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Genmab (GMAB) in Q3 2022, closing a stake of 355 shares — an estimated $12K sold.

Patriot Financial Group Insurance Agency first reported a position in GMAB in Q1 2020 and held it in 10 quarters. The position peaked at $29K in Q2 2020. 194 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Genmab position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 355 Genmab shares in Q3 2022, an estimated $12K.
  • Patriot Financial Group Insurance Agency first reported a position in Genmab in Q1 2020 and held it in 10 quarters.
  • Patriot Financial Group Insurance Agency's Genmab position peaked at $29K in Q2 2020.
  • 194 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.